National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C03DA01	ALDACTONE	B	Spironolactone - 25mg	25mg	Tablet	237,860 L.L
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
L02BG03	ARIMIDEX	B	Anastrozole - 1mg	1mg	Tablet, film coated	3,202,377 L.L
A07EC02	ASACOL	B	Mesalazine - 1g/100ml	1g/100ml	Enema	2,748,158 L.L
C09CA04	APROVEL	B	Irbesartan - 150mg	150mg	Tablet, film coated	651,764 L.L
V01AA	ACARIZAX 12 SQ-HDM ORAL LYOPHILISATE	B	Allergen extracts - 12 SQ-HDM		Tablet, lyophilised	9,366,451 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	8,454,523 L.L
A07EC02	ASACOL	B	Mesalazine - 1600mg	1600mg	Tablet, modified release	12,310,378 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
C09CA04	APROVEL	B	Irbesartan - 300mg	300mg	Tablet, film coated	651,764 L.L
C05A	ANTROLIN	B	Nifedipine - 0.3%, Lidocaine - 1.5%		Cream	1,333,092 L.L
M01AB16	AIRTAL 100MG 20	B	Aceclofenac - 100mg	100mg	Tablet, film coated	471,689 L.L
D10AD06	AKLIEF	B	Trifarotene - 50mcg/g	50mcg/g	Cream	4,359,425 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	490,837,809 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
R05X	ACTISOUFRE	B	Sulfure de Sodium - 13mg, Saccharomyces Cerevisiae - 500mg		Solution	740,457 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 8mg	8mg	Tablet	526,786 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 180mg	180mg	Tablet, film coated	493,595,998 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 16mg	16mg	Tablet	705,517 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 0.5%	0.5%	Injectable solution	1,441,943 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 1%	1%	Injectable solution	1,732,213 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 3%	3%	Injectable solution	2,576,146 L.L
R06AB54	ALERGICAL EXPECTORANT	B	Chlorpheniramine maleate - 50mg/100ml, Guaifenesin - 2000mg/100ml, Dihydroxypropyltheophylline - 500mg/100ml, Paracetamol - 2000mg/100ml		Syrup	485,127 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactivé de l'hépatite A adsorbé)	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
N01BB58	ARTINIBSA 4% WITH EPINEPHRINE 1/100000	B	Articaine HCl - 4%, Epinephrine - 1/100.000		Injectable solution	1,968,729 L.L
M01AE01	ADVIL	B	Ibuprofen - 200mg	200mg	Tablet	321,178 L.L
M01AE01	ADVIL LIQUI-GELS	B	Ibuprofen - 200mg	200mg	Capsule	464,970 L.L
L01EG02	AFINITOR	B	Everolimus - 5mg	5mg	Tablet	149,280,650 L.L
L01EG02	AFINITOR	B	Everolimus - 10mg	10mg	Tablet	214,897,705 L.L

...